Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol.

Saved in:
Bibliographic Details
Title: Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol.
Authors: Azim L; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.; Northern Centre for Mood Disorders, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Al-Ashmori S; Biostatistics Research Group, Newcastle University Population Health Sciences Institute, Newcastle upon Tyne, UK., Butcher C; Newcastle Clinical Trials Unit, Newcastle upon Tyne, UK., Cipriani A; Oxford Health NHS Foundation Trust, Oxford, UK.; University of Oxford Department of Psychiatry, Oxford, UK., Chew-Graham CA; Keele University School of Medicine, Keele, UK., Clare E; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK., Clark E; Newcastle Clinical Trials Unit, Newcastle upon Tyne, UK., Cole M; Biostatistics Research Group, Newcastle University Population Health Sciences Institute, Newcastle upon Tyne, UK., Carella S; Northern Centre for Mood Disorders, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Dixon L; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK., Evans J; Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK.; Bristol Medical School, Bristol, UK., Gergel T; Bipolar UK, University College London Division of Psychiatry, London, UK.; Cardiff University Division of Psychological Medicine and Clinical Neurosciences, Cardiff, UK., Gibson J; The McPin Foundation, London, UK., Hancock HC; Newcastle Clinical Trials Unit, Newcastle upon Tyne, UK., Hoppe I; Keele University School of Medicine, Keele, UK., Kessler D; Bristol Medical School, Bristol, UK., Kabir T; University of Oxford Department of Psychiatry, Oxford, UK., Lewis G; University College London Division of Psychiatry, London, UK., Mathias A; Newcastle Clinical Trials Unit, Newcastle upon Tyne, UK., Morris R; Mental Health and Clinical Neurosciences, University of Nottingham School of Medicine, Nottingham, UK.; Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK., Nixon N; Mental Health and Clinical Neurosciences, University of Nottingham School of Medicine, Nottingham, UK.; Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK., Simon J; University of Oxford Department of Psychiatry, Oxford, UK.; Medical University of Vienna Department of Health Economics, Vienna, Austria., Teare MD; Biostatistics Research Group, Newcastle University Population Health Sciences Institute, Newcastle upon Tyne, UK., Wahba M; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.; Northern Centre for Mood Disorders, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Wall L; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.; Northern Centre for Mood Disorders, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Walmsley Z; Newcastle Clinical Trials Unit, Newcastle upon Tyne, UK., Wienand D; Medical University of Vienna Department of Health Economics, Vienna, Austria., Wolstenhulme F; Newcastle Clinical Trials Unit, Newcastle upon Tyne, UK., Ahuja N; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.; Northern Centre for Mood Disorders, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Watson S; Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK stuart.watson@newcastle.ac.uk.; Northern Centre for Mood Disorders, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
Corporate Authors: Lived Experience Advisory Panel
Source: BMJ open [BMJ Open] 2026 Mar 19; Vol. 16 (3), pp. e112677. Date of Electronic Publication: 2026 Mar 19.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-6055
DOI:10.1136/bmjopen-2025-112677